Open Access
Issue
BioMedicine
Volume 7, Number 1, March 2017
Article Number 4
Number of page(s) 5
DOI https://doi.org/10.1051/bmdcn/2017070104
Published online 03 March 2017
  1. Lynch S, Brogden RN. Etodolac: A preliminary review of its pharmacodynamic activity and therapeutic use. Drugs. 1986; 31: 288300. [CrossRef] [Google Scholar]
  2. Karbowski A.. A global safety evaluation of etodolac. Clinical Rheumatology. 1989; 8 Suppl 1: 73–9. [CrossRef] [PubMed] [Google Scholar]
  3. Balfour JA, Buckley MM. Etodolac: A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain states. Drugs. 1991; 42: 274–99. [CrossRef] [PubMed] [Google Scholar]
  4. Serni U.. Global safety of etodolac: reports from worldwide postmarketing surveillance studies. Rheumatology International. 1990; 10: Suppl: 23–7. [CrossRef] [PubMed] [Google Scholar]
  5. Jones RA. Etodolac: An overview of a selective COX-2 inhibitor. Inflammopharmacology. 1999; 7: 269. [CrossRef] [PubMed] [Google Scholar]
  6. Jones RA. Etodolac (Lodine[sup®]): Profile of an established selective COX-2 inhibitor. Inflammopharmacology. 2001; 9: 63–70. [CrossRef] [Google Scholar]
  7. eHealthMe study from FDA and social media reports. Review: could etodolac cause pancreatitis? http://www.ehealthme.com/ds/etodolac/pancreatitis/#print [cited in 2016 August 1]. [Google Scholar]
  8. National Health Insurance Research Database, Taiwan. http://nhird.nhri.org.tw/en/index.html [cited in 2016 March 1, English version]. [Google Scholar]
  9. Lai SW, Liao KF, Liao CC, Muo CH, Liu CS, Sung FC. Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine (Baltimore). 2010; 89: 295–9. [CrossRef] [PubMed] [Google Scholar]
  10. Lai SW, Muo CH, Liao KF, Sung FC, Chen PC. Risk of acute pancreatitis in type 2 diabetes and risk reduction on anti-diabetic drugs: a population-based cohort study in Taiwan. Am J Gastroenterol. 2011; 106: 1697–704. [CrossRef] [Google Scholar]
  11. Hung SC, Liao KF, Lai SW, Li CI, Chen WC. Risk factors associated with symptomatic cholelithiasis in Taiwan: a population-based study. BMC Gastroenterol. 2011; 11: 11–111. [CrossRef] [PubMed] [Google Scholar]
  12. Liao KF, Lai SW, Li CI, Chen WC. Diabetes mellitus correlates with increased risk of pancreatic cancer: a population-based cohort study in Taiwan. J Gastroenterol Hepatol. 2012; 27: 709–13. [CrossRef] [PubMed] [Google Scholar]
  13. Chen HY, Lai SW, Muo CH, Chen PC, Wang IJ. Ethambutol-induced optic neuropathy: a nationwide population-based study from Taiwan. Br J Ophthalmol. 2012; 96: 1368–71. [CrossRef] [PubMed] [Google Scholar]
  14. Hung SC, Lai SW, Tsai PY, Chen PC, Wu HC, Lin WH, et al. Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk. Br J Cancer. 2013; 108: 1778–83. [CrossRef] [PubMed] [Google Scholar]
  15. Lai HC, Lin CC, Cheng KS, Kao JT, Chou JW, Peng CY, et al. Increased incidence of gastrointestinal cancers among patients with pyogenic liver abscess: a population-based cohort study. Gastroenterology. 2014; 146: 129–37. [CrossRef] [PubMed] [Google Scholar]
  16. Kuo SC, Lai SW, Hung HC, Muo CH, Hung SC, Liu LL, etal. Association between comorbidities and dementia in diabetes mellitus patients: population-based retrospective cohort study. J Diabetes Complications. 2015; 29: 1071–6. [CrossRef] [PubMed] [Google Scholar]
  17. Yang SP, Muo CH, Wang IK, Chang YJ, Lai SW, Lee CW, et al. Risk of type 2 diabetes mellitus in female breast cancer patients treated with morphine: A retrospective population-based time-dependent cohort study. Diabetes Res Clin Pract. 2015; 110: 285–90. [CrossRef] [PubMed] [Google Scholar]
  18. Cheng KC, Chen YL, Lai SW, Mou CH, Tsai PY, Sung FC. Patients with chronic kidney disease are at an elevated risk of dementia: a population-based cohort study in Taiwan. BMC Nephrol. 2012; 13: 1471–2369. [CrossRef] [Google Scholar]
  19. Cheng KC, Chen YL, Lai SW, Tsai PY, Sung FC. Risk of esophagus cancer in diabetes mellitus: a population-based case-control study in Taiwan. BMC Gastroenterol. 2012; 12: 12–177. [CrossRef] [PubMed] [Google Scholar]
  20. Chen YL, Cheng KC, Lai SW, Tsai IJ, Lin CC, Sung FC, et al. Diabetes and risk of subsequent gastric cancer: a population-based cohort study in Taiwan. Gastric Cancer. 2013; 16: 389–96. [CrossRef] [PubMed] [Google Scholar]
  21. Lai SW, Liao KF, Muo CH, Hsieh DPH. No Association between Statin Use and Pancreatic Cancer Risk in Taiwan. In: KUWAIT MEDICAL JOURNAL. 2013: 251–2. [Google Scholar]
  22. Hung SC, Hung SR, Lin CL, Lai SW, Hung HC. Use of celecoxib correlates with increased relative risk of acute pancreatitis: a case-control study in Taiwan. Am J Gastroenterol. 2015; 110: 1490–6. [CrossRef] [Google Scholar]
  23. Lai SW, Lai HC, Lin CL, Liao KF. Finasteride use and acute pancreatitis in Taiwan. J Clin Pharmacol. 2015; 55: 657–60. [CrossRef] [PubMed] [Google Scholar]
  24. Liao KF, Lin CL, Lai SW, Chen WC. Parkinson’s disease and risk of pancreatic cancer: a population-based case-control study in Taiwan. Neurology Asia. 2015; 20. [Google Scholar]
  25. Lai SW, Lin CL, Liao KF. Association of Meloxicam Use with the Risk of Acute Pancreatitis: A Case-Control Study. Clin Drug Investig. 2015; 35: 653–7. [CrossRef] [Google Scholar]
  26. Liao KF, Lin CL, Lai SW, Chen WC. Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: A population-based case-control study in Taiwan. Eur J Intern Med. 2016; 27: 76–9. [CrossRef] [PubMed] [Google Scholar]
  27. Lai SW, Lin CL, Liao KF. Rheumatoid Arthritis and Risk of Pyogenic Liver Abscess in Taiwan. International Medical Journal. 2016; 23: 267–8. [Google Scholar]
  28. Lin HF, Lai SW, Lin WY, Liu CS, Lin CC, Chang CM. Prevalence and factors of elevated alanine aminotransferase in central Taiwan - a retrospective study. BioMedicine. 2016; 6: 016–0011. [CrossRef] [Google Scholar]
  29. Cheng KC, Lin WY, Liu CS, Lin CC, Lai HC, Lai SW. Association of different types of liver disease with demographic and clinical factors. BioMedicine. 2016; 6: 016–0016. [CrossRef] [Google Scholar]
  30. Liao KF, Lin CL, Lai SW, Chen WC. Zolpidem Use Associated With Increased Risk of Pyogenic Liver Abscess: A Case-Control Study in Taiwan. Medicine. 2015; 94: 0000000000001302. [CrossRef] [PubMed] [Google Scholar]
  31. Lai SW, Lin CL, Chen WC, Liao KF. Correlation Between Use of Zopiclone and Risk of Hip Fracture in Elderly Adults: A Case-Control Study in Taiwan. J Am Geriatr Soc. 2015; 63: 2534–7. [CrossRef] [PubMed] [Google Scholar]
  32. Lai SW, Lin HF, Lin CL, Liao KF. No association between losartan use and acute pancreatitis in hypertensive patients. Eur J Hosp Pharm. doi:10.1136/ejhpharm-2015-000840. [Google Scholar]
  33. Andersen V, Sonne J, Andersen M. Spontaneous reports on drug-induced pancreatitis in Denmark from 1968 to 1999. Eur J Clin Pharmacol. 2001; 57: 517–21. [CrossRef] [PubMed] [Google Scholar]
  34. Lancashire RJ, Cheng K, Langman MJ. Discrepancies between population-based data and adverse reaction reports in assessing drugs as causes of acute pancreatitis. Aliment Pharmacol Ther. 2003; 17: 887–93. [CrossRef] [PubMed] [Google Scholar]